A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding

Daniel J Birmingham1, Fawzi Irshaid, Katherine F Gavit

  • 1Division of Nephrology, Department of Internal Medicine, The Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, United States. Dan.Birmingham@osumc.edu <Dan.Birmingham@osumc.edu>

Insights

A common CR1 gene variation introduces an extra cysteine, significantly reducing its binding ability to complement proteins C3b and C4b. This CR1 polymorphism does not appear to increase the risk for SLE or lupus nephritis.

Area of Science:

  • Immunology
  • Genetics

Background:

  • The type one complement receptor (CR1) plays a crucial role in the immune system by binding complement proteins C3b and C4b.
  • CR1's structure comprises repeating units called short consensus repeats (SCRs), each containing cysteines essential for function via disulfide bonds.

Purpose of the Study:

  • To identify and characterize a CR1 single nucleotide polymorphism (1597C>T) associated with an additional cysteine residue (483R>C).
  • To investigate the functional impact of this CR1 polymorphism on C3b and C4b binding.
  • To assess the association of this CR1 polymorphism with Systemic Lupus Erythematosus (SLE) and lupus nephritis.

Main Methods:

  • Identification of a CR1 single nucleotide polymorphism (1597C>T) leading to an amino acid change (483R>C) in SCR 8.
  • Expression of CR1 constructs with and without the 483-C variation to assess C3b/C4b binding.
  • Analysis of carrier frequencies in African American and Caucasian populations.
  • Comparison of 483-C carrier status between SLE patients and healthy controls.

Main Results:

  • The 483-C polymorphism was found in 6.3% of African Americans and 2.4% of Caucasians.
  • Expression constructs with the 483-C residue showed over 80% reduction in binding to C3b, C3bi, and C4b compared to wild-type.
  • Full-length CR1 from carriers also exhibited reduced C3b and C4b binding, with the effect modulated by the number of binding domains.
  • Carrier status for 483-C was not found to be a risk factor for SLE or lupus nephritis in race-matched comparisons.

Conclusions:

  • The identified CR1 polymorphism (483R>C) significantly impairs the binding of CR1 to key complement proteins.
  • Despite the functional impact on complement binding, this CR1 variation is not associated with an increased risk for SLE or lupus nephritis.
  • The precise physiological role of this CR1 polymorphism warrants further investigation.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...